Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Abernethy

Showing results (21-30 of 221) with videos related to

Pageof 23
Sort By:
Clinical Pharmacokinetics|March 1, 1982
Pharmacokinetics of drugs in obesityD R Abernethy, D J Greenblatt
Biochemical and Biophysical Research Communications|March 16, 1992
Verapamil blocks basal and angiotensin II-induced RNA synthesis of rat aortic vascular smooth muscle cellsN S Andrawis, D R Abernethy
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker ratsE L Todd, D R Abernethy
Clinical Pharmacology and Therapeutics|June 1, 1989
Calcium antagonists in geriatric patients: diltiazem in elderly persons with hypertensionS C Montamat, D R Abernethy
The American Journal of Cardiology|December 14, 1987
Acute and chronic studies of diltiazem in elderly versus young hypertensive patientsD R Abernethy, S C Montamat
Geriatrics|August 1, 1987
Cardiac drugs: adjusting their use in aging patientsJ B Schwartz, D R Abernethy
British Journal of Clinical Pharmacology|August 1, 1987
N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensivesS C Montamat, D R Abernethy
The New England Journal of Medicine|November 5, 1999
Calcium-antagonist drugsD R Abernethy, J B Schwartz
The American Journal of Cardiology|April 1, 1984
Lidocaine disposition in obesityD R Abernethy, D J Greenblatt
Biochemical Pharmacology|March 15, 1977
Effect of drugs which alter microsomal drug-metabolizing enzyme activity on rat hepatic cholesterol biosynthesisD R Abernethy, D L Azarnoff
Pageof 23

Showing results (21-30 of 221) with videos related to

Sort By:
Pageof 23
Clinical Pharmacokinetics|March 1, 1982
Pharmacokinetics of drugs in obesityD R Abernethy, D J Greenblatt
Biochemical and Biophysical Research Communications|March 16, 1992
Verapamil blocks basal and angiotensin II-induced RNA synthesis of rat aortic vascular smooth muscle cellsN S Andrawis, D R Abernethy
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker ratsE L Todd, D R Abernethy
Clinical Pharmacology and Therapeutics|June 1, 1989
Calcium antagonists in geriatric patients: diltiazem in elderly persons with hypertensionS C Montamat, D R Abernethy
The American Journal of Cardiology|December 14, 1987
Acute and chronic studies of diltiazem in elderly versus young hypertensive patientsD R Abernethy, S C Montamat
Geriatrics|August 1, 1987
Cardiac drugs: adjusting their use in aging patientsJ B Schwartz, D R Abernethy
British Journal of Clinical Pharmacology|August 1, 1987
N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensivesS C Montamat, D R Abernethy
The New England Journal of Medicine|November 5, 1999
Calcium-antagonist drugsD R Abernethy, J B Schwartz
The American Journal of Cardiology|April 1, 1984
Lidocaine disposition in obesityD R Abernethy, D J Greenblatt
Biochemical Pharmacology|March 15, 1977
Effect of drugs which alter microsomal drug-metabolizing enzyme activity on rat hepatic cholesterol biosynthesisD R Abernethy, D L Azarnoff
Pageof 23